1. Approved Drug Products with Therapeutic Equivalence Evaluations, “Orange Book,” 2003. (accessed 20.04.20.).
2. Avery, M., 1998. Mova Pharm. Corp. v. Shalala, 140 F.3d 1060. Supra, Note 7, 178.
3. Chen, J., 2019. New Drug Application. Available from: (accessed 19.04.20.).
4. Chen, J., 2020. Orange Book. Available from: (accessed 20.04.20.).
5. Drug master files: Guidelines, Center for Drug Evaluation and Research Food and Drug Administration, Department of Health and Human Services, September 1989. Available from: (accessed 20.04.20.).